shortagewatch

Home / Sensory organs / Olopatadine

ATC S01GX09 · Other Antiallergics · updated 2 Nov 2026

Olopatadine shortage

As of 2 Nov 2026, Olopatadine has a reported shortage in 2 of the 16 countries we track (Canada, Japan), covering 8 products from 6 companies.

Is there an Olopatadine shortage?

Yes. As of 2 Nov 2026, Olopatadine is reported short in 2 of the 16 countries we track: Canada, Japan. No company has given a return date.

Countries2/16
Products8packs or presentations
Companies63 listed
Short since1 Sep 20188.2 years ago
Earliest returnnot givencompany estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada5 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan3 products shortNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

CanadaJapan
20222023202420252026ACT OLOPATADINE 0.1% (1)ACT OLOPATADINE 0.1% (1)ACT OLOPATADINE 0.2% (1)ACT OLOPATADINE 0.2% (1)APO-OLOPATADINE (5 ML)APO-OLOPATADINE (5 ML)APO-OLOPATADINE (2.5 ML)APO-OLOPATADINE (2.5 ML)JAMP-OLOPATADINE (5 mL)JAMP-OLOPATADINE (5 mL)オロパタジン塩酸塩ドライシロップ1%「日本臓器」オロパタジン塩酸塩ドライシロップ1%「日本臓器」オロパタジン塩酸塩OD錠5mg「サワイ」オロパタジン塩酸塩OD錠5mg「サワイ」オロパタジン塩酸塩OD錠2.5mg「トーワ」オロパタジン塩酸塩OD錠2.5mg「トーワ」today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Teva2 TEVAApotex2Jamp1日本臓器製薬1Sawai1 4887Towa (Pensa)1 4553

Listed: Teva TEVA · NYSE / TASE, Sawai 4887 · Tokyo, Towa (Pensa) 4553 · Tokyo

Compared with similar medicines

ATC group S01GX · Other Antiallergics
Ketotifen6/16Azelastine3/16Bilastine3/16Levocabastine2/16Olopatadine2/16Cromoglicic Acid, Combinations1/16Epinastine1/16Spaglumic Acid1/16

Affected products

CountryProductCompanySinceExpected backReason
CAACT OLOPATADINE 0.1% (1)ACTAVIS PHARMA COMPANY1 Sep 2018not givenManufacturing problem
Disruption of the manufacture of the drug
CAACT OLOPATADINE 0.2% (1)ACTAVIS PHARMA COMPANY1 Sep 2018not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO-OLOPATADINE (5 ML)APOTEX INC1 Jun 2020not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO-OLOPATADINE (2.5 ML)APOTEX INC26 Mar 2024not givenManufacturing problem
Disruption of the manufacture of the drug
CAJAMP-OLOPATADINE (5 mL)JAMP PHARMA CORPORATION7 Aug 2025not givenManufacturing problem
Disruption of the manufacture of the drug
オロパタジン塩酸塩ドライシロップ1%「日本臓器」 limited日本臓器製薬17 Jan 2025not givenOther
オロパタジン塩酸塩OD錠5mg「サワイ」 limitedSawai15 May 2025not givenManufacturing problem
オロパタジン塩酸塩OD錠2.5mg「トーワ」 limitedTowa (Pensa)30 May 2025not givenManufacturing problem

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there an Olopatadine shortage?

Yes. As of 2 Nov 2026, Olopatadine is reported short in 2 of the 16 countries we track: Canada, Japan. No company has given a return date.

When will Olopatadine be back in stock?

No return date has been given; Canada: no date given; Japan: no date given. These are company estimates reported to each authority.

Why is Olopatadine in short supply?

The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.

Which companies have Olopatadine shortages?

Teva, Apotex, Jamp, 日本臓器製薬, Sawai, Towa (Pensa).